Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

To change this, Alzheimer’s Research UK is now calling on the government to speed up the search for dementia treatments by doubling funding for dementia research to over £160 million a year, in ...

AI Helps Unravel a Cause of Alzheimer's Disease and Identify a Therapeutic Candidate Apr. 25, 2025 — A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is ...

AI Helps Unravel a Cause of Alzheimer's Disease and Identify a Therapeutic Candidate Apr. 25, 2025 — A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is ...

In recent years, there have been many pivotal moments for anyone with an interest in dementia and disease-modifying therapies. High-profile approvals and rejections of new treatments have sparked ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function. Researchers at the University ...

Last month, the FDA granted approval to Eli Lilly’s donanemab - or Kisunla - for the treatment of Alzheimer’s disease. Its approval was based on the treatment demonstrating what the FDA ...

About three years ago, at age 46, he was diagnosed with early-onset Alzheimer’s disease. Although Rios has been doing well on a new treatment he receives through a clinical trial, Ribot is ...

This Review summarizes preclinical and clinical evidence highlighting the potential of incretin-based drugs as treatments of neurodegenerative diseases, such as Alzheimer’s disease or Parkinson ...